Search Within

Joachim Yahalom

Formats
  1. Journal Article (281)
  2. Meeting Abstract (243)
  3. Book Section (67)
  4. Review (9)
  5. Conference Paper (6)
  6. Research Letter (6)
  7. Guidelines (5)
  8. Correspondence (4)
  9. Editorial (3)
  10. Book Whole (1)
Groups
  1. Radiation Oncology, Department of (625)
  2. Survivorship Research (625)
  3. Department of Medicine (283)
  4. Hematologic Malignancies, Division of (277)
  5. Center for Hematologic Malignancies (248)
  6. Lymphoma (205)

More Groups

People
  1. Andrew Zelenetz (116)
  2. Brandon Imber (116)
  3. Craig Moskowitz (87)
  4. David Straus (82)
  5. Carla Hajj (73)
  6. Ariela Noy (71)

More People

Years
  1. 2025 (9)
  2. 2024 (26)
  3. 2023 (48)
  4. 2022 (26)
  5. 2021 (25)
  6. 2020 (24)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (125)
  2. Blood (96)
  3. Journal of Clinical Oncology (46)
  4. Hematological Oncology (34)
  5. Journal of the National Comprehensive Cancer Network (31)
  6. Leukemia and Lymphoma (17)

More Publications

Publishers
  1. Elsevier Inc. (161)
  2. American Society of Hematology (105)
  3. American Society of Clinical Oncology (46)
  4. Wiley Blackwell (43)
  5. Harborside Press (31)
  6. Lippincott Williams & Wilkins (28)

More Publishers

Results (625)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rare variants of ATM and risk for Hodgkin's disease and radiation-associated breast cancers
    Journal Article

    Offit, K.; Gilad, S.; Paglin, S.; Kolachana, P.; Roisman, L. C.; Nafa, K.; Yeugelowitz, V.; Gonzales, M.; Robson, M.; McDermott, D.; more...
    Clinical Cancer Research (2002)

    Fulltext@MSK | Save
  • Hodgkin's disease
    Book Section

    Yahalom, J.; Straus, D.
    In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 5th ed (2001)

    Fulltext@MSK | Save
  • Superior vena cava syndrome
    Book Section

    Yahalom, J.
    In DeVita, V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 6th ed (2001)

    Fulltext@MSK | Save
  • Cardiac toxicity
    Book Section

    Steinherz, L. J.; Yahalom, J.
    In DeVita, V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 6th ed (2001)

    Fulltext@MSK | Save
  • Primary central nervous system lymphoma
    Book Section

    DeAngelis, L. M.; Yahalom, J.
    In DeVita, V. T. Jr; Hellman, S.; Rosenberg, S. A. (Eds.) Cancer: Principles and Practice of Oncology. 6th ed (2001)

    Fulltext@MSK | Save
  • Excellent local control with involved-field radiotherapy following CHOP chemotherapy: Analysis of 145 patients with early-stage intermediate-grade non-Hodgkin's lymphoma
    Meeting Abstract

    Roy, I.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2001)

    Fulltext@MSK | Save
  • Radiotherapy for lung cancer: Can IMRT decrease the risk of esophagitis
    Meeting Abstract

    Giraud, P.; Rosenzweig, K. E.; Yorke, E.; Yahalom, J.; Fournier-Bidoz, N.; Spirou, S.; Mageras, G.; Amols, H.; Leibel, S. A.
    International Journal of Radiation Oncology, Biology, Physics (2001)

    Fulltext@MSK | Save
  • Vacuolar-proton-ATPase is involved in the response of cancer cells to ionizing radiation and is a new target for radiosensitization
    Meeting Abstract

    Hollister, T. C.; Paglin, S.; Mcmahill, M. S.; Gilles, F.; Yahalom, J.
    International Journal of Radiation Oncology, Biology, Physics (2001)

    Fulltext@MSK | Save
  • Results of a prospective randomized trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) alone vs. ABVD plus radiation therapy for early stage non bulky Hodgkin's disease
    Meeting Abstract

    Straus, D. J.; Yahalom, J.; Zelenetz, A. D.; Qin, J.; Myers, J.; Moskowitz, C. H.; Noy, A.; Bertino, J. R.; Portlock, C. S.
    Blood (2001)

    Fulltext@MSK | Save
  • Phase II study of accelerated fractionation involved field radiotherapy (IFRT), total body irradiation (TBI), ifosfamide and continuous infusion etoposide with autologous stem cell transplantation (ASCT) in the treatment of patients with relapsed and primary refractory aggressive non-Hodgkins lymphoma (NHL)
    Meeting Abstract

    Moskowitz, C. H.; Yahalom, J.; Zelenetz, A. D.; Kewalramani, T.; Malhotra, S.; Nimer, S. D.
    Blood (2001)

    Fulltext@MSK | Save